Intestinal microbiota containing Barnesiella species cures vancomycin-resistant Enterococcus faecium colonization. 2013

Carles Ubeda, and Vanni Bucci, and Silvia Caballero, and Ana Djukovic, and Nora C Toussaint, and Michele Equinda, and Lauren Lipuma, and Lilan Ling, and Asia Gobourne, and Daniel No, and Ying Taur, and Robert R Jenq, and Marcel R M van den Brink, and Joao B Xavier, and Eric G Pamer
Infectious Diseases Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York, USA. ubeda_carmor@gva.es

Bacteria causing infections in hospitalized patients are increasingly antibiotic resistant. Classical infection control practices are only partially effective at preventing spread of antibiotic-resistant bacteria within hospitals. Because the density of intestinal colonization by the highly antibiotic-resistant bacterium vancomycin-resistant Enterococcus (VRE) can exceed 10(9) organisms per gram of feces, even optimally implemented hygiene protocols often fail. Decreasing the density of intestinal colonization, therefore, represents an important approach to limit VRE transmission. We demonstrate that reintroduction of a diverse intestinal microbiota to densely VRE-colonized mice eliminates VRE from the intestinal tract. While oxygen-tolerant members of the microbiota are ineffective at eliminating VRE, administration of obligate anaerobic commensal bacteria to mice results in a billionfold reduction in the density of intestinal VRE colonization. 16S rRNA gene sequence analysis of intestinal bacterial populations isolated from mice that cleared VRE following microbiota reconstitution revealed that recolonization with a microbiota that contains Barnesiella correlates with VRE elimination. Characterization of the fecal microbiota of patients undergoing allogeneic hematopoietic stem cell transplantation demonstrated that intestinal colonization with Barnesiella confers resistance to intestinal domination and bloodstream infection with VRE. Our studies indicate that obligate anaerobic bacteria belonging to the Barnesiella genus enable clearance of intestinal VRE colonization and may provide novel approaches to prevent the spread of highly antibiotic-resistant bacteria.

UI MeSH Term Description Entries
D007422 Intestines The section of the alimentary canal from the STOMACH to the ANAL CANAL. It includes the LARGE INTESTINE and SMALL INTESTINE. Intestine
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D004269 DNA, Bacterial Deoxyribonucleic acid that makes up the genetic material of bacteria. Bacterial DNA
D005260 Female Females
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001438 Bacteroidaceae A family of gram-negative bacteria found primarily in the intestinal tracts and mucous membranes of warm-blooded animals. Its organisms are sometimes pathogenic.
D012329 RNA, Bacterial Ribonucleic acid in bacteria having regulatory and catalytic roles as well as involvement in protein synthesis. Bacterial RNA
D012336 RNA, Ribosomal, 16S Constituent of 30S subunit prokaryotic ribosomes containing 1600 nucleotides and 21 proteins. 16S rRNA is involved in initiation of polypeptide synthesis. 16S Ribosomal RNA,16S rRNA,RNA, 16S Ribosomal,Ribosomal RNA, 16S,rRNA, 16S
D016908 Gram-Positive Bacterial Infections Infections caused by bacteria that retain the crystal violet stain (positive) when treated by the gram-staining method. Bacterial Infections, Gram-Positive,Infections, Gram-Positive Bacterial,Bacterial Infection, Gram-Positive,Bacterial Infections, Gram Positive,Gram Positive Bacterial Infections,Gram-Positive Bacterial Infection,Infection, Gram-Positive Bacterial,Infections, Gram Positive Bacterial
D016984 Enterococcus faecium A species of gram-positive, coccoid bacteria whose organisms are normal flora of the intestinal tract. Unlike ENTEROCOCCUS FAECALIS, this species may produce an alpha-hemolytic reaction on blood agar and is unable to utilize pyruvic acid as an energy source. Streptococcus faecium

Related Publications

Carles Ubeda, and Vanni Bucci, and Silvia Caballero, and Ana Djukovic, and Nora C Toussaint, and Michele Equinda, and Lauren Lipuma, and Lilan Ling, and Asia Gobourne, and Daniel No, and Ying Taur, and Robert R Jenq, and Marcel R M van den Brink, and Joao B Xavier, and Eric G Pamer
August 1994, American journal of infection control,
Carles Ubeda, and Vanni Bucci, and Silvia Caballero, and Ana Djukovic, and Nora C Toussaint, and Michele Equinda, and Lauren Lipuma, and Lilan Ling, and Asia Gobourne, and Daniel No, and Ying Taur, and Robert R Jenq, and Marcel R M van den Brink, and Joao B Xavier, and Eric G Pamer
February 1999, Journal of clinical microbiology,
Carles Ubeda, and Vanni Bucci, and Silvia Caballero, and Ana Djukovic, and Nora C Toussaint, and Michele Equinda, and Lauren Lipuma, and Lilan Ling, and Asia Gobourne, and Daniel No, and Ying Taur, and Robert R Jenq, and Marcel R M van den Brink, and Joao B Xavier, and Eric G Pamer
February 1999, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases,
Carles Ubeda, and Vanni Bucci, and Silvia Caballero, and Ana Djukovic, and Nora C Toussaint, and Michele Equinda, and Lauren Lipuma, and Lilan Ling, and Asia Gobourne, and Daniel No, and Ying Taur, and Robert R Jenq, and Marcel R M van den Brink, and Joao B Xavier, and Eric G Pamer
July 1995, Archives of internal medicine,
Carles Ubeda, and Vanni Bucci, and Silvia Caballero, and Ana Djukovic, and Nora C Toussaint, and Michele Equinda, and Lauren Lipuma, and Lilan Ling, and Asia Gobourne, and Daniel No, and Ying Taur, and Robert R Jenq, and Marcel R M van den Brink, and Joao B Xavier, and Eric G Pamer
October 1997, Infection control and hospital epidemiology,
Carles Ubeda, and Vanni Bucci, and Silvia Caballero, and Ana Djukovic, and Nora C Toussaint, and Michele Equinda, and Lauren Lipuma, and Lilan Ling, and Asia Gobourne, and Daniel No, and Ying Taur, and Robert R Jenq, and Marcel R M van den Brink, and Joao B Xavier, and Eric G Pamer
December 1995, Infection control and hospital epidemiology,
Carles Ubeda, and Vanni Bucci, and Silvia Caballero, and Ana Djukovic, and Nora C Toussaint, and Michele Equinda, and Lauren Lipuma, and Lilan Ling, and Asia Gobourne, and Daniel No, and Ying Taur, and Robert R Jenq, and Marcel R M van den Brink, and Joao B Xavier, and Eric G Pamer
June 2000, Revista medica de Chile,
Carles Ubeda, and Vanni Bucci, and Silvia Caballero, and Ana Djukovic, and Nora C Toussaint, and Michele Equinda, and Lauren Lipuma, and Lilan Ling, and Asia Gobourne, and Daniel No, and Ying Taur, and Robert R Jenq, and Marcel R M van den Brink, and Joao B Xavier, and Eric G Pamer
May 2017, Cell host & microbe,
Carles Ubeda, and Vanni Bucci, and Silvia Caballero, and Ana Djukovic, and Nora C Toussaint, and Michele Equinda, and Lauren Lipuma, and Lilan Ling, and Asia Gobourne, and Daniel No, and Ying Taur, and Robert R Jenq, and Marcel R M van den Brink, and Joao B Xavier, and Eric G Pamer
January 2020, Open forum infectious diseases,
Carles Ubeda, and Vanni Bucci, and Silvia Caballero, and Ana Djukovic, and Nora C Toussaint, and Michele Equinda, and Lauren Lipuma, and Lilan Ling, and Asia Gobourne, and Daniel No, and Ying Taur, and Robert R Jenq, and Marcel R M van den Brink, and Joao B Xavier, and Eric G Pamer
March 1995, Antimicrobial agents and chemotherapy,
Copied contents to your clipboard!